Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News

October 28, 2019 — The Gore Cardioform ASD Occluder received European CE mark clearance in early October. The device ...

Home October 28, 2019
Home
News | Hemodynamic Support Devices

October 28, 2019 — Nearly two years of real-world outcomes data on Abiomed’s Impella RP heart pump shows that when ...

Home October 28, 2019
Home
News | Congenital Heart

October 24, 2019 — Investigators at the University of Arizona Steele Children's Research Center are leading a statewide ...

Home October 24, 2019
Home
News | Magnetic Resonance Imaging (MRI)

October 21, 2019 — Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger predictor of ...

Home October 21, 2019
Home
The U.S. Food and Drug Administration (FDA) has granted market clearance for AstraZeneca's dapagliflozin (Farxiga) to reduce the risk of hospitalization for heart failure (HF) in adults with type 2 diabetes (T2D) and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors.
Feature | Heart Failure | Dave Fornell, Editor

October 21, 2019 – The U.S. Food and Drug Administration (FDA) has granted market clearance for AstraZeneca's ...

Home October 21, 2019
Home
News | Pulmonary Embolism

October 18, 2019 —­­ Patients with lung blood clots who smoke are more likely to be readmitted for lung blood clots than ...

Home October 18, 2019
Home
Videos | Vascular Closure Devices

Ashish Pershad, M.D., chief of interventional cardiology, Banner University Medical Center, Phoenix, explains the trend ...

Home October 17, 2019
Home
News | Heart Failure

October 16, 2019 — Researchers have shown for the first time in preclinical studies that the drug Aliskiren can delay ...

Home October 16, 2019
Home
Videos | Hemodynamic Support Devices

Jeffrey J. Popma, M.D., director of interventional cardiology clinical services at Beth Israel Deaconess Medical Center ...

Home October 16, 2019
Home
Videos | Structural Heart

Vivian Ng, M.D., assistant professor of medicine and an interventional cardiologist at the NewYork-Presbyterian/Columbia ...

Home October 16, 2019
Home
News | Hypertension

October 10. 2019 — Late-breaking results from its MODERATO II double-blind, randomized study of BackBeat Cardiac ...

Home October 10, 2019
Home
TCT 2019 Late-breaking Presentations in the main arena. The top interventional cardiology studies of 2019. #TCT #TCT19 #TCT2019
Feature | TCT

October 10, 2019 — Here are the Cardiovascular Research Foundation (CRF) 12 late-breaking trials and 16 late-breaking ...

Home October 11, 2019
Home
News | Angiography

October 9, 2019 — In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-date ...

Home October 09, 2019
Home
Videos | Heart Valve Technology

Torsten Vahl, M.D., director of experimental and translational research, Structural Heart and Valve Center and at the ...

Home October 09, 2019
Home
News | Stent Grafts

October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug ...

Home October 09, 2019
Home
Subscribe Now